End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.09 CNY | -4.68% |
|
-5.80% | +4.75% |
May. 29 | Sino-Agri Leading Biosciences Names Chairman | MT |
Apr. 25 | Sino-Agri Leading Biosciences Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.75% | 595M | - | ||
+13.19% | 926M | - | C+ | |
-39.33% | 610M | - | - | |
-27.33% | 261M | - | - | |
+14.10% | 260M | - | - | |
-.--% | 101M | - | - | |
+28.45% | 85.69M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603970 Stock
- Ratings Sino-Agri Leading Biosciences Co.,Ltd